Siskinds LLP seeks to recover compensation for Canadians who were prescribed Invokana and who suffered related injuries.
Invokana (canagliflozin) is a prescription medication indicated to lower blood sugar in adults with type 2 diabetes. Invokana is also available in combination with metformin, under the brand name Invokamet.
Invokana May Cause Serious Injuries
According to various research studies and reports made by the FDA and Health Canada, Invokana may cause serious side effects and injuries, including:
- Increased risk of lower limb amputations (toe, foot, and leg)
- Increased risk of acute renal failure
- Acute kidney injuries
On September 6, 2017 Health Canada issued a Dear Healthcare Professional Letter advising practitioners that an approximately two-fold increased risk of surgical lower limb amputation (primarily of the toe and midfoot but also of the leg) has been observed in two long-term clinical studies in type 2 diabetes patients with established cardiovascular disease and treated with Invokana. Subsequently, a black box warning regarding lower limb amputations was added to the drug product label.
On May 16, 2016, Health Canada issued a Dear Healthcare Professional Letter advising that serious, sometimes life-threatening and fatal cases of diabetic ketoacidosis (DKA) have been reported in patients prescribed Invokana.
On October 16, 2015, Health Canada completed a Safety Review which found a link between acute kidney injury and the use of Invokana.
Siskinds LLP’s class action alleges that the defendant failed to adequately warn individuals that the use of Invokana increases the risk of serious injuries and complications.
Are You Part of the Invokana Class Action?
If you were prescribed Invokana, and suffered one of the injuries list above, we encourage you to join Siskinds LLP’s Invokana Class Action. Please email Invokana@siskinds.com or call us toll-free, at (800) 461-6166 x 2210 (English).